cbdMD (YCBD) Deferred Taxes (2016 - 2021)
cbdMD (YCBD) reported Deferred Taxes of $130000.0 for Q3 2021, down 85.47% on a YoY basis from $895000.0 in Q3 2020, and up 226.21% sequentially from -$103000.0 in Q2 2021.
cbdMD (YCBD) Deferred Taxes (2016 - 2021) Analysis & Trends
cbdMD (YCBD) has 6 years of Deferred Taxes data on file, last reported at $130000.0 in Q3 2021.
- For the quarter ending Q3 2021, Deferred Taxes fell 85.47% year-over-year to $130000.0; the trailing twelve-month figure through Jun 2022 stood at $130000.0 (down 92.17% YoY), and the FY2021 full-year result was $895000.0, up 166.53% from the prior year.
- Deferred Taxes grew to $130000.0 in Q3 2021, from -$103000.0 in the prior quarter.
- In the past five years, Deferred Taxes ranged from a high of $2.2 million in Q4 2019 to a low of -$4.5 million in Q2 2020.
- A 5-year average of -$159350.0 and a median of -$28000.0 in 2017 frame the typical range for Deferred Taxes.
- Peak annual rise in Deferred Taxes reached 1784.44% in 2019, while the deepest fall reached 4573.91% in 2019.
- Tracing YCBD's Deferred Taxes over 5 years: stood at -$33000.0 in 2017, then plunged by 303.03% to -$133000.0 in 2018, then jumped by 1784.44% to $2.2 million in 2019, then tumbled by 114.82% to -$332000.0 in 2020, then surged by 139.16% to $130000.0 in 2021.
- Business Quant data shows YCBD's Deferred Taxes at $130000.0 in Q3 2021, -$103000.0 in Q2 2021, and $1.2 million in Q1 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -22.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 34.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 25.90 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -69.70 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | -61.10 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | cbdMD | 438,678.80 | -2.95 Mn | 3.00 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2021 | 130,000.00 |
| Jun 30, 2021 | -103,000.00 |
| Mar 31, 2021 | 1.20 Mn |
| Dec 31, 2020 | -332,000.00 |
| Sep 30, 2020 | 895,000.00 |
| Jun 30, 2020 | -4.48 Mn |
| Dec 31, 2019 | 2.24 Mn |
| Sep 30, 2019 | -129,000.00 |
| Jun 30, 2019 | -1.09 Mn |
| Mar 31, 2019 | -1.08 Mn |
| Dec 31, 2018 | -133,000.00 |
| Sep 30, 2018 | -22,000.00 |
| Jun 30, 2018 | 62,000.00 |
| Mar 31, 2018 | -23,000.00 |
| Dec 31, 2017 | -33,000.00 |
| Sep 30, 2017 | -17,250.00 |
| Jun 30, 2017 | -36,642.00 |
| Mar 31, 2017 | 76,892.00 |
| Dec 31, 2016 | 2,000.00 |